Sepsis Updates: Less is More?

Sepsis recognition still sits at the fault line between sensitivity and specificity. SIRS and qSOFA identify different patients, SEP-1 still drives emergency department workflow, and newer bedside thinking argues that indiscriminate 30 mL/kg fluid loading may worsen outcomes rather than rescue them.

Sepsis Definitions and Bedside Recognition

• Rivers trial legacy: Early goal-directed therapy changed sepsis care, but the durable wins were early antibiotics, serial lactates, fluids, and vasopressors rather than routine ScvO2 targets or transfusion-driven protocols.
• SIRS versus qSOFA: SIRS is highly sensitive but nonspecific, while qSOFA is more specific and can miss serious illness; that tradeoff matters because hospitals often build protocols and quality metrics around one framework.
• Sepsis 3 reframing: Sepsis 3 dropped the term severe sepsis and defines septic shock by vasopressor need plus lactate elevation, emphasizing circulatory and metabolic failure rather than a simple progression label.
• qSOFA mortality signal: A qSOFA score of 2 or more tracks with increased mortality risk, but it performs better as a prognostic warning than as a broad emergency department screening tool.
• Protocol alignment nuance: There is no universal winner between SIRS and qSOFA, so clinicians need to know which definition their local system uses for alerts, audits, and SEP-1 compliance. We get into the practical tension in the episode.

SEP-1 and Modern Sepsis Management

• Bundle clock essentials: SEP-1 still centers on lactate, blood cultures before antibiotics, broad-spectrum IV antibiotics within 3 hours, and early fluids, making documentation as important as the orders themselves.
• Balanced crystalloid preference: Lactated Ringer's or Plasma-Lyte are preferred over normal saline because chloride-heavy resuscitation is linked to non-anion gap acidosis, renal injury, and longer length of stay.
• Less fluid, more judgment: The default 30 mL/kg bolus should be based on ideal body weight, but CMS also permits withholding excess fluid when the chart clearly documents why. We walk through that documentation nuance in the episode.
• Antibiotic spectrum discipline: Early antibiotics remain core care, yet broader is not always better; when the source is reasonably clear, narrower therapy may outperform reflexive shotgun coverage and better supports stewardship.
• Blood culture selectivity: False-positive blood cultures create real downstream harm, so cultures are most useful when the source is unclear, shock is present, or gram-positive bacteremia is a serious concern.
• Lactate trend caveats: Lactate is a strong risk-stratification marker, but serial values can be confounded by catecholamines and impaired hepatic clearance, so an uptrend should trigger reassessment rather than automatic protocolism.

References:

1. Rivers E, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345(19):1368-1377. PMID: 11794169
2. ARISE Investigators; ANZICS Clinical Trials Group, Peake SL, et al. Goal-directed resuscitation for patients with early septic shock. N Engl J Med. 2014;371(16):1496-1506. PMID: 25272316
3. Escobar GJ, et al. Risk-adjusting hospital inpatient mortality using automated inpatient, outpatient, and laboratory databases. Med Care. 2008;46(3):232-239. PMID: 18388836
4. van Walraven C, et al. The Kaiser Permanente inpatient risk adjustment methodology was valid in an external patient population. J Clin Epidemiol. 2010;63(7):798-803. PMID: 20004550
5. Song YH, et al. Predicting factors associated with clinical deterioration of sepsis patients with intermediate levels of serum lactate. Shock. 2012;38(3):249-254. PMID: 22683735
6. Liu V, et al. Fluid volume, lactate values, and mortality in sepsis patients with intermediate lactate values. Ann Am Thorac Soc. 2013;10(5):466-473. PMID: 24004068
7. Puskarich MA, et al. Prognosis of emergency department patients with suspected infection and intermediate lactate levels: a systematic review. J Crit Care. 2014;29(3):334-339. PMID: 24559577
8. Winters ME, et al. What is the Preferred Resuscitation Fluid for Patients with Severe Sepsis and Septic Shock?. J Emerg Med. 2017;53(6):928-939. PMID: 29079487
9. Malbrain ML, et al. Fluid overload, de-resuscitation, and outcomes in critically ill or injured patients: a systematic review with suggestions for clinical practice. Anaesthesiol Intensive Ther. 2014;46(5):361-380. PMID: 25432556
10. De Backer D, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362(9):779-789. PMID: 20200382
11. De Backer D, et al. Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis*. Crit Care Med. 2012;40(3):725-730. PMID: 22036860
12. Vasu TS, et al. Norepinephrine or dopamine for septic shock: systematic review of randomized clinical trials. J Intensive Care Med. 2012;27(3):172-178. PMID: 21436167
13. McIntyre WF, et al. Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock: A Systematic Review and Meta-analysis. JAMA. 2018;319(18):1889-1900. PMID: 29801010
14. Nagendran M, et al. Comparative safety and efficacy of vasopressors for mortality in septic shock: A network meta-analysis. J Intensive Care Soc. 2016;17(2):136-145.
15. Gamper, G. et al. Vasopressors for hypotensive shock. Cochrane Database Syst Rev 2016. PMID: 28979478
16. Cardenas-Garcia J, et al. Safety of peripheral intravenous administration of vasoactive medication. J Hosp Med. 2015;10(9):581-585. PMID: 26014852
17. Loubani OM, et al. A systematic review of extravasation and local tissue injury from administration of vasopressors through peripheral intravenous catheters and central venous catheters. J Crit Care. 2015;30(3):653.e9-653.e6.53E17. PMID: 25669592
18. Medlej K, et al. Complications from Administration of Vasopressors Through Peripheral Venous Catheters: An Observational Study. J Emerg Med. 2018;54(1):47-53. PMID: 29110979
19. Ricard JD, Salomon L, Boyer A, et al. Central or peripheral catheters for initial venous access of ICU patients: a randomized controlled trial. Crit Care Med. 2013;41(9):2108-2115. PMID: 23782969
20. Burston J, et al. A Role for Antimicrobial Stewardship in Clinical Sepsis Pathways: a Prospective Interventional Study. Infect Control Hosp Epidemiol. 2017;38(9):1032-1038. PMID: 28693625
21. Garnacho-Montero J, et al. De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock. Intensive Care Med. 2014;40(1):32-40. PMID: 24026297